Our proficiency in this domain enables us trade, export and supply our clients highly effective Doxorubicin Hydrochloride Injection. This injection is formulated by vendors' professionals using superior grade chemical substances in conformity with medical industry standards. Offered injection is extensively used for treating multiple myeloma, ovarian cancer and breast cancer. In addition, this medicine can be availed by our esteemed clients in safe packaging options and at marginal rates.
Doxorubicin has been used successfully to produce regression in disseminated neoplastic conditions such as acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms' tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, Hodgkin's disease, malignant lymphoma, and bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types.
Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer.
Developed and Managed by Infocom Network Private Limited.